NCT03445702View on ClinicalTrials.gov

Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

October 27, 2020

Study Completion Date

October 27, 2020

Conditions
Diabetes Mellitus, Type 2Metformin Adverse Reaction
Interventions
DRUG

Metformin

Metformin 1000mg once

DRUG

Placebo

Sugar pill manufactured to mimic metformin 1000mg

Trial Locations (1)

63110

Saint Louis University, St Louis

All Listed Sponsors
collaborator

Washington University School of Medicine

OTHER

lead

St. Louis University

OTHER

NCT03445702 - Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I | Biotech Hunter | Biotech Hunter